Sort
82,697 grants matching “vaccine development”
Boston HIV CTU
$4,700,628Daniel R Kuritzkes · Brigham And Women'S Hospital · UM1 · FY2022 · AI
Vaccine and Treatment Evaluation Units
$4,699,209Nadine Georges Rouphael · Emory University · UM1 · FY2022 · AI
Preclinical Development of Non-Invasive Anthrax Vaccine
$4,698,162Ligocyte Pharmaceuticals, Inc. · UC1 · FY2005 · AI
Targeting Neutralizing Epitopes in the HIV Envelope
$4,688,092Susan W Barnett · Novartis Vaccines And Diagnostics, Inc. · P01 · FY2010 · AI
Building on the success of the adoptive immunotherapy of cancer
$4,687,435Nicholas P Restifo · Basic Sciences · Z01 · FY2007 · CA
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network
$4,687,361Thomas R Fleming · Fred Hutchinson Cancer Research Center · U01 · FY2006 · AI
Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria
$4,685,791Frank Malinowski · Eveliqure Biotechnologies, Gmbh · N01 · FY2025 · AI
Innovative Platforms for Antimicrobial Therapy and Vaccine Development
$4,685,717Dennis L. Kasper · Harvard Medical School · U19 · FY2018 · AI
I4C 2.0: Immunotherapy for Cure
$4,677,761Dan H. Barouch · Beth Israel Deaconess Medical Center · UM1 · FY2022 · AI
EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL)
$4,675,225Thomas Denny · Duke University · N01 · FY2020 · AI
HIV Preventive Vaccine and Monoclonal Antibody Studies
$4,674,744Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Biodefense/Emerging Infection Vaccine Studies
$4,674,742Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Pandemic Influenza Translational Research and novel universal countermeasure development
$4,672,598Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
I4C 2.0: Immunotherapy for Cure
$4,669,992Dan H. Barouch · Beth Israel Deaconess Medical Center · UM1 · FY2023 · AI
Harnessing Human DC Subsets for Improved Muscosal Vaccines
$4,668,879Yong-Jun Liu · Baylor Research Institute · U19 · FY2012 · AI
Safeguard the household: comprehensive AIDS research
$4,667,751Wits Health Consortium (Pty), Ltd · U19 · FY2005 · AI
Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants
$4,666,000Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2017 · AI
Human Papillomavirus (HPV) Natural History, Genomics and Risk Assessment
$4,664,368Mark Schiffman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV
$4,663,588Viral Genomix, Inc. · N01 · FY2008 · AI
Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09
$4,656,240Cheryl Cohen · National Health Laboratory Service · U01 · FY2019 · IP
Southern California Primary Infection Program
$4,655,390Douglas D Richman · University Of California, San Diego · U01 · FY2006 · AI
Development of Technologies to Facilitate the Use of and Response to Vaccines
$4,654,902Dan Stinchcomb · Inviragen, Inc. · N01 · FY2012 · AI
I4C 2.0: Immunotherapy for Cure
$4,653,643Dan H. Barouch · Beth Israel Deaconess Medical Center · UM1 · FY2025 · AI
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit
$4,646,184Constance Ann Benson · University Of California, San Diego · U01 · FY2011 · AI
Project 4: Protein nanoparticle vaccines
$4,642,108Neil King · University Of Washington · U19 · FY2024 · AI